Titanium IBR

Bovine Rhinotracheitis Vaccine

Modified Live Virus

from the Signature cell line^®

Titanium IBR Indications

This product has been shown to be effective for the vaccination of healthy cattle against infectious bovine rhinotracheitis virus (IBR). The duration of immunity has not been determined. This product was licensed prior to the requirement to establish a minimum age for use. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

DIRECTIONS AND DOSAGE: Rehydrate the desiccated vial with accompanying diluent and shake well. Inject 2 mL subcutaneously or intramuscularly using aseptic technique. The need for annual booster vaccinations has not been established for this product. The presence of maternal antibody is known to interfere with the development of active immunity in calves and additional boosters will be required in most young animals. For advice on revaccination frequency, consult your veterinarian. Do not mix with other products, except as specified on the label.

CAUTIONS: Store at 35-46°F (2-8°C). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days of slaughter. In case of human exposure, contact a physician. Inactivate unused contents before disposal. Allergic reactions may follow the use of vaccines; ANTIDOTE: Epinephrine. This product has not been tested in pregnant animals. DO NOT USE IN PREGNANT COWS OR IN CALVES NURSING PREGNANT COWS. ABORTIONS MAY RESULT.

FOR USE IN ANIMALS ONLY

Manufactured by:

Diamond Animal Health, Inc., Des Moines, Iowa 50327 U.S.A.

U.S. Veterinary License No. 213

Product Code No. 1101.20

Distributed by:

Elanco US Inc., Greenfield, IN 46140 U.S.A.

1-800-428-4441

Titanium, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

CPN: 1131140.0